He lists what Japanese clinics advertise BPC-157, TB-500 and Epitalon for, and notes the FDA has flagged missing human safety data for several of them.
Recap by typeshit. Full story at note.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Data on 22,694 women showed higher semaglutide uptake across contraceptive types. Lead author Mille Dybdal Bager warns the link is not cause and effect.
BusinessWorld Online makes the case that Ozempic shouldn't be thought of as a weight loss drug. Only the headline was available, so tap through for the full argument.
Loading…